Works matching IS 22351795 AND DT 2020 AND VI 9 AND IP 3

Results: 12

Pathological Complete Response in Conversion Hepatectomy Induced by Lenvatinib for Advanced Hepatocellular Carcinoma.

Published in:

2020

By:

Ryota Matsuki;
Kirio Kawai;
Yutaka Suzuki;
Masaharu Kogure;
Tetsuya Nakazato;
Daisuke Naruge;
Naohiro Okano;
Satowa Seki;
Yoshihiko Ohmori;
Naohiro Kawamura;
Hiroshi Kamma;
Tadakazu Hisamatsu;
Junji Shibahara;
Toshiyuki Mori;
Junji Furuse;
Yoshihiro Sakamoto

Publication type:

Case Study

Reply to the Letter to the Editor: "Comparison of the Safety and Efficacy of Yttrium-90 Radioembolization for Nonalcoholic Fatty Liver Disease-Associated and Hepatitis B Virus-Associated Hepatocellular Carcinoma".

Published in:

2020

By:

Schotten, Clemens;
Wedemeyer, Heiner;
Best, Jan

Publication type:

Letter to the Editor

Comparison of Safety and Efficacy of Yttrium-90 Radioembolization for Nonalcoholic Fatty Liver Disease-Associated and Hepatitis B Virus-Associated Hepatocellular Carcinoma.

Published in:

2020

By:

Lei Liang;
Li-Yang Sun;
Yong-Kang Diao;
Tian Yang

Publication type:

Letter to the Editor

Dual Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Inhibition Elicits Antitumor Immunity and Enhances Programmed Cell Death-1 Checkpoint Blockade in Hepatocellular Carcinoma.

Published in:

Liver Cancer (2235-1795), 2020, v. 9, n. 3, p. 338, doi. 10.1159/000505695

By:

Haijing Deng;
Anna Kan;
Ning Lyu;
Luwen Mu;
Yi Han;
Longzhong Liu;
Yanyu Zhang;
Youfa Duan;
Shuangye Liao;
Shaolong Li;
Qiankun Xie;
Tianxiao Gao;
Yanrong Li;
Zhenfeng Zhang;
Ming Zhao

Publication type:

Article

Development and Validation of a Nomogram for Patients with Nonmetastatic BCLC Stage C Hepatocellular Carcinoma after Stereotactic Body Radiotherapy.

Published in:

Liver Cancer (2235-1795), 2020, v. 9, n. 3, p. 326, doi. 10.1159/000505693

By:

Wen-Yen Huang;
Chiao-Ling Tsai;
Jenny Y. Que;
Cheng-Hsiang Lo;
Yu-Ju Lin;
Yang-Hong Dai;
Jen-Fu Yang;
Po-Chien Shen;
Mei-Hsuan Lee;
Jason Chia-Hsien Cheng

Publication type:

Article

Exploratory Analysis to Identify Candidates Benefitting from Combination Therapy of Transarterial Chemoembolization and Sorafenib for First-Line Treatment of Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Observational Study.

Published in:

Liver Cancer (2235-1795), 2020, v. 9, n. 3, p. 308, doi. 10.1159/000505692

By:

Zhexuan Wang;
Enxin Wang;
Wei Bai;
Dongdong Xia;
Rong Ding;
Jiaping Li;
Qiuhe Wang;
Lei Liu;
Junhui Sun;
Wei Mu;
Hui Zhao;
Xingnan Pan;
Guoliang Shao;
Xiaoli Zhu;
Guowen Yin;
Haibin Shi;
Jianbing Wu;
Zhengyu Lin;
Shufa Yang;
Jueshi Liu

Publication type:

Article

How to Best Detect Portal Vein Tumor Thrombosis in Patients with Hepatocellular Carcinoma Meeting the Milan Criteria: Gadoxetic Acid-Enhanced MRI versus Contrast-Enhanced CT.

Published in:

Liver Cancer (2235-1795), 2020, v. 9, n. 3, p. 293, doi. 10.1159/000505191

By:

Jae Seok Bae;
Jeong Min Lee;
Jeong Hee Yoon;
Siwon Jang;
Jin Wook Chung;
Kyung Bun Lee;
Nam-Joon Yi;
Jeong-Hoon Lee

Publication type:

Article

Direct-Acting Antiviral Agents Reduce the Risk of Malignant Transformation of Hepatobiliary Phase-Hypointense Nodule without Arterial Phase Hyperenhancement to Hepatocellular Carcinoma on Gd-EOB-DPTAEnhanced Imaging in the Hepatitis C Virus-Infected Liver

Published in:

Liver Cancer (2235-1795), 2020, v. 9, n. 3, p. 261, doi. 10.1159/000504889

By:

Yoshiaki Shimizu;
Kuniaki Arai;
Taro Yamashita;
Tatsuya Yamashita;
Tetsuro Shimakami;
Kazunori Kawaguchi;
Kazuya Kitamura;
Yoshio Sakai;
Eishiro Mizukoshi;
Masao Honda;
Azusa Kitao;
Kazuto Kozaka;
Satoshi Kobayashi;
Shuichi Kaneko

Publication type:

Article

Better Efficacy of Ramucirumab in Japanese Patients than in the Global Population with Unresectable Hepatocellular Carcinoma.

Published in:

2020

By:

Masatoshi Kudo

Publication type:

Editorial

Publisher's Note.

Published in:

Liver Cancer (2235-1795), 2020, v. 9, n. 3, p. 231, doi. 10.1159/000509008

By:

Karger, Gabriella;
Ebneter, Daniel

Publication type:

Article

Pretreatment Heterogeneous Enhancement Pattern of Hepatocellular Carcinoma May Be a Useful New Predictor of Early Response to Lenvatinib and Overall Prognosis.

Published in:

Liver Cancer (2235-1795), 2020, v. 9, n. 3, p. 275, doi. 10.1159/000505190

By:

Yusuke Kawamura;
Masahiro Kobayashi;
Junichi Shindoh;
Yuta Kobayashi;
Kayoko Kasuya;
Tomoya Sano;
Shunichiro Fujiyama;
Tetsuya Hosaka;
Satoshi Saitoh;
Yoshiyuki Suzuki;
Kenji Ikeda;
Yasuji Arase;
Masaji Hashimoto;
Hiromitsu Kumada

Publication type:

Article

A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements.

Published in:

Liver Cancer (2235-1795), 2020, v. 9, n. 3, p. 245, doi. 10.1159/000507370

By:

Masatoshi Kudo;
Kwang-Hyub Han;
Sheng-Long Ye;
Jian Zhou;
Yi-Hsiang Huang;
Shi-Ming Lin;
Chung-Kwe Wang;
Masafumi Ikeda;
Lam Chan, Stephen;
Su Pin Choo;
Shiro Miyayama;
Ann Lii Cheng

Publication type:

Article